Evidence map›Paper›PMID 23419875›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2013

Dopamine modulates reward-related vigor.

Ulrik Beierholm, Marc Guitart-Masip, Marcos Economides, Rumana Chowdhury, Emrah Düzel, Ray Dolan, Peter Dayan

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 1 synthesis or guideline pooled it, 237 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Acetylcholine and noradrenaline enhance foraging optimality in humans.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Trial
  6. Dopamine Modulates Dynamic Decision-Making during Foraging.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Cue-induced craving increases impulsivity via changes in striatal value signals in problem gamblers.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Dopamine Boosts Motivation for Prosocial Effort in Parkinson's Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  17. Article
  18. Striatal Dopamine Actions and Movement: Inferences from Parkinson Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Review
  19. Article
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ulrik BeierholmCentre for Computational Neuroscience and Cognitive Robotics, University of Birmingham, Edgbaston, UK. u.beierholm@bham.ac.uk
Marc Guitart-Masip
Marcos Economides
Rumana Chowdhury
Emrah Düzel
Ray Dolan
Peter Dayan
University College London · GBOxford Centre for Computational Neuroscience · GBUniversity of Birmingham · GBWellcome Centre for Human Neuroimaging · GB

Funding

Wellcome Trust 078865Wellcome Trust 091593Wellcome Trust 098362Wellcome Trust 098362/Z/12/ZWellcome Trust Grant 091593/Z/10/Z
6 · The paper itself

Abstract

Subjects routinely control the vigor with which they emit motoric responses. However, the bulk of formal treatments of decision-making ignores this dimension of choice. A recent theoretical study suggested that action vigor should be influenced by experienced average reward rate and that this rate is encoded by tonic dopamine in the brain. We previously examined how average reward rate modulates vigor as exemplified by response times and found a measure of agreement with the first suggestion. In the current study, we examined the second suggestion, namely the potential influence of dopamine signaling on vigor. Ninety healthy subjects participated in a double-blind experiment in which they received one of the following: placebo, L-DOPA (which increases dopamine levels in the brain), or citalopram (which has a selective, if complex, effect on serotonin levels). Subjects performed multiple trials of a rewarded odd-ball discrimination task in which we varied the potential reward over time in order to exercise the putative link between vigor and average reward rate. Replicating our previous findings, we found that a significant fraction of the variance in subjects' responses could be explained by our experimentally manipulated changes in average reward rate. Crucially, this relationship was significantly stronger under L-Dopa than under Placebo, suggesting that the impact of average reward levels on action vigor is indeed subject to a dopaminergic influence.

Indexed as

RewardAdolescentAdultCitalopramDopamineDouble-Blind MethodFemaleHumansLevodopaMaleMotivationPhotic StimulationPsychomotor PerformanceReaction TimeYoung AdultCitalopramDopamineLevodopa

Identifiers

PMID23419875
PMCPMC3682144
OpenAlexW2164961539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.